Search Results
You are looking at 1-6 of 6
Miranda K. Suer,
Justin D. Crane,
Todd A. Trappe,
Bozena Jemiolo,
Scott W. Trappe, and
Matthew P. Harber
Article Category: Research Article
Volume/Issue: Volume 84: Issue 7
Online Publication Date: Jul 01, 2013
Page Range: 669 – 674
R. W. Mayes
Article Category: Research Article
Volume/Issue: Volume 53: Issue 4
Online Publication Date: Apr 01, 1982
DOI:
Page Range: 332 – 335
Kaveri Mukherjee and
N. C. Ghosh
Article Category: Research Article
Volume/Issue: Volume 54: Issue 3
Online Publication Date: Mar 01, 1983
DOI:
Page Range: 236 – 240
Michael J. Saliba Jr.
Article Category: Research Article
Volume/Issue: Volume 41: Issue 11
Online Publication Date: Nov 01, 1970
DOI:
Page Range: 1302 – 1306
John R. Casley-SmithD.Sc., M.D. and
Judith R. Casley-SmithPh.D., M.A.
Article Category: Research Article
Volume/Issue: Volume 67: Issue 1
Online Publication Date: Jan 01, 1996
DOI:
Page Range: 52 – 56
John Caruso,
Neel Patel,
Joseph Wellwood, and
Lance Bollinger
Article Category: Review Article
Volume/Issue: Volume 94: Issue 12
Online Publication Date: Dec 01, 2023
Page Range: 923 – 933
greater than USRDA guidelines, did not stop resorption increases, and higher Ca +2 intakes alone did not limit bone loss. It was concluded that higher Ca +2 intakes are an adjunctive but important aid to limit BMD loss during unloading.
7
Dietary treatments also include omega-3 and isovaleric fatty acids (Ω-3FA, IVFA).
6
,
16
,
44
The Ω-3FA eicosapentanoic acid (EPA) inhibits NF- K B and the ubiquitin proteolytic pathway that cause muscle and bone loss.
6
,
17
EPA (50 µM · d −1 ) inhibited RANKL-induced differentiation and